Diagnostics Medical Devices Machine Learning for Early Detection of Hypoxic‑Ischemic Brain Injury After Cardiac Arrest Despite the many advances in the field of resuscitation post cardiac arrest, hypoxic-ischemic brain injury (HIBI) leaves many survivors with severe neurological disability. Patients… Interests: Imaging, Imaging Agents, Machine Learning/Artificial Intelligence Reference ID: 21-T-045 Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Antibody-Targeted Enzymatic Chemoprotection Cytotoxic chemotherapy involves drugs that inhibit cellular division, killing or blocking the growth of cancer cells. However, chemotherapy blocks the growth of noncancerous cells,… Interests: Oncology Reference ID: 23-T-076 Desired Partnership: Co-development, Licensing IP: Patent Pending
Materials A Controllable Synthesis Method Of Layered Oxides By Electrochemical Assisted Ion-Exchange Lithium-rich layered oxides are promising cathode materials with remarkable electrochemical performance that will revolutionize the electronics, transportation, battery, and grid energy storage industries. The… Interests: Chemical Synthesis, Electronic Reference ID: 22-T-122 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics SARS-CoV-2 Therapeutics Point Of Care Technology For SARS-CoV-2 Detection and Neutralization SARS-CoV-2’s enters cells when the receptor binding domain (RBD) of its spike protein (S-protein) interacts with angiotensin-converting enzyme 2 (ACE2). In order to block… Interests: Antibody, Antibody Reference ID: 21-T-014 Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Anti-CD73(NT5E) Antibodies Specific To The Tumor Microenvironment CD73 is an ectonucleotidase tethered by a glycosylphosphatidyl anchor to the extracellular side of many cell types. Along with NTPDase-1 CD39, CD73 is an… Interests: Antibody, Oncology, Radiosensitizer Reference ID: 19-T-151 Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Engineered Multipurpose Antibody Module Platform Traditionally, antibodies were produced using animal immunization methodologies. While this approach is still in broad use, recombinant display technologies have now assumed the leading role… Interests: Antibody, Antibody, Drug Development Tool Reference ID: 19-T-138 Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics Nanovaccine That Activates The NLRP3 Inflammasome & Enhances Tumor Specific Activation Of Anti-Cancer Immunity A major attention of vaccine adjuvant development has been focused on development of robust antibody-mediated protection against pathogens. However, such adjuvants have failed to… Interests: Immunology, Immunooncology, Immunotherapy Reference ID: 19-T-069 Desired Partnership: Co-development, Licensing IP: Patent Pending
Hardware Software Grace: A Data Scalable Real-Time Video Communication System Real-time video communications are essential to the daily routine of users for online meetings, cloud gaming, and interactive virtual reality. Retransmitting data packets that… Interests: Communications, Communications Reference ID: 23-T-070 Desired Partnership: Co-development, Licensing IP: Patent Pending
Research Tools SARS-CoV-2 Therapeutics Neutralizing Monoclonal Antibodies Against SARS-CoV-2 The landscape of SARS-CoV-2 is experiencing a novel development of viral variants harboring mutations that can escape even the most highly potent antibodies against… Interests: Antibody, Antibody Reference ID: 22-T-070 Desired Partnership: Co-development, Licensing IP: Patent Pending
Therapeutics A New Genetic Medicine Strategy For Treating Neurological Disorders Synaptic transmission and plasticity are fundamental to neuronal functions, and alterations of synaptic protein expression are direct causes of autism, intellectual disability (ID), and… Interests: Biologics, Neurology Reference ID: 23-T-011 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics Identification of Structurally Novel BTK Mutations That Drive Resistance to BTK Inhibitors in CLL and Non-Hodgkin Lymphomas Non-Hodgkin’s lymphoma is among the most common types of cancer in the US consisting of a diverse group of lymphocytic malignancies. Most of these… Interests: Oncology, Oncology Hematopoietic, Point-of-Care Reference ID: 16-T-041 Desired Partnership: Co-development, Licensing IP: Patent Issued
Therapeutics A Microbial Consortia That Depresses Klebsiella Pneumoniae Drug-resistant Enterobacteriaceae (particularly K. pneumoniae) are a growing cause of hospital-acquired infections, pneumonia, and antibiotic failure. Broad-spectrum antibiotics exacerbate dysbiosis and resistance, while fecal… Interests: Infectious Disease Reference ID: 22-T-130 Desired Partnership: Co-development, Licensing IP: Patent Pending
